Preclinical and Clinical Investigations of Mood Stabilizers for Huntington's Disease: What Have We Learned?
Huntington's disease: from molecular pathogenesis to clinical treatment - ScienceDirect
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease | Physiological Reviews
Huntington disease: MedlinePlus Genetics
Frontiers | Impaired Redox Signaling in Huntington's Disease: Therapeutic Implications | Molecular Neuroscience
Mechanism of immune dysfunction in Huntington's disease. (A) In normal... | Download Scientific Diagram
An Introduction to Huntington's Disease
Deregulated Splicing Is a Major Mechanism of RNA-Induced Toxicity in Huntington's Disease - ScienceDirect
Researchers identify increased translation as a novel pathogenic mechanism in Huntington's disease
Huntington's disease: underlying molecular mechanisms and emerging concepts: Trends in Biochemical Sciences
Pathogenesis of Huntington's Disease: How to Fight Excitotoxicity and Transcriptional Dysregulation | IntechOpen
The global prevalence of Huntington's disease: a systematic review and discussion | Neurodegenerative Disease Management
Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities | Acta Pharmacologica Sinica
AJNS – African Journal of Neurological Sciences | » HUNTINGTON'S DISEASE: A PERPLEXING NEUROLOGICAL DISEASE
Huntington's disease: Molecular basis of pathology and status of current therapeutic approaches (Review)
Frontiers | Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches | Molecular Neuroscience
Huntington's disease - Wikipedia
RNAi mechanisms in Huntington's disease therapy: siRNA versus shRNA | Translational Neurodegeneration | Full Text
Huntington's disease: a synaptopathy?: Trends in Molecular Medicine
Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis. | Semantic Scholar
Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities | Acta Pharmacologica Sinica
Huntington's Disease: Cell
Huntington disease: Advances in the understanding of its mechanisms - ScienceDirect
A Pathogenic Mechanism in Huntington's Disease Involves Small CAG-Repeated RNAs with Neurotoxic Activity
